RAPT Therapeutics (RAPT) Change in Accured Expenses (2020 - 2024)
Historic Change in Accured Expenses for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $3.1 million.
- Therapeutics' Change in Accured Expenses rose 445211.27% to $3.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$8.5 million, marking a year-over-year decrease of 21532.38%. This contributed to the annual value of -$8.5 million for FY2024, which is 21532.38% down from last year.
- Therapeutics' Change in Accured Expenses amounted to $3.1 million in Q4 2024, which was up 445211.27% from -$4.4 million recorded in Q3 2024.
- Therapeutics' Change in Accured Expenses' 5-year high stood at $7.3 million during Q1 2023, with a 5-year trough of -$6.4 million in Q2 2024.
- Over the past 5 years, Therapeutics' median Change in Accured Expenses value was $235500.0 (recorded in 2021), while the average stood at $295450.0.
- As far as peak fluctuations go, Therapeutics' Change in Accured Expenses crashed by 54350.6% in 2023, and later soared by 445211.27% in 2024.
- Quarter analysis of 5 years shows Therapeutics' Change in Accured Expenses stood at -$2.8 million in 2020, then increased by 7.06% to -$2.6 million in 2021, then skyrocketed by 89.95% to -$263000.0 in 2022, then skyrocketed by 73.0% to -$71000.0 in 2023, then surged by 4452.11% to $3.1 million in 2024.
- Its last three reported values are $3.1 million in Q4 2024, -$4.4 million for Q3 2024, and -$6.4 million during Q2 2024.